In TME, IL-6 could be produced by inflammatory cells 9, cancer cells 10, and MSCs 10-12, while hyperactivation of IL-6/JAK/STAT3 signaling pathways within a TME contributes to aggressiveness and progression of cancer through multifaced mechanisms. The gene discussed is STAT3; the disease is cancer.